uniQure (QURE) Enterprise Value (2015 - 2026)
uniQure (QURE) posted quarterly Enterprise Value of -$810.3 million for Q2 2026, down 114.96% year-over-year from $5.4 billion in Q2 2025, and down 38.15% quarter-over-quarter from -$586.6 million in Q1 2026.
Analysis
uniQure (QURE) Enterprise Value (2015 - 2026) Analysis & Trends
uniQure's Enterprise Value history runs 12 years deep, the most recent figure standing at -$810.3 million for Q2 2026.
- In Q2 2026, Enterprise Value fell 114.96% year-over-year to -$810.3 million; the TTM figure through Jun 2026 stood at -$810.3 million (down 114.96% YoY), while the FY2025 annual figure was -$622.5 million, down 69.39% from the prior year.
- Enterprise Value for Q2 2026 stood at -$810.3 million, down from -$586.6 million in the prior quarter.
- The five-year high for Enterprise Value was -$315.3 million in Q1 2023, with the low at -$810.3 million in Q2 2026.
- The 5-year median for Enterprise Value is -$524.7 million (2022), against an average of -$523.4 million.
- The sharpest annual moves came in 2024 and 2026: Enterprise Value surged 40.52% in 2024, then sank 114.96% in 2026.
- uniQure's Enterprise Value stood at -$352.8 million in 2022, then slumped by 75.12% to -$617.9 million in 2023, then soared by 40.52% to -$367.5 million in 2024, then tumbled by 69.39% to -$622.5 million in 2025, then slumped by 30.17% to -$810.3 million in 2026.
- Business Quant data shows QURE's Enterprise Value at -$810.3 million in Q2 2026, -$586.6 million in Q1 2026, and -$622.5 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | uniQure | 2.95 Bn | 2.95 Bn | 5.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.38 Bn |
| Mar 31, 2026 | 444.04 Mn |
| Dec 31, 2025 | 869.18 Mn |
| Sep 30, 2025 | 2.93 Bn |
| Jun 30, 2025 | 387.85 Mn |
| Mar 31, 2025 | 170.79 Mn |
| Dec 31, 2024 | 497.61 Mn |
| Sep 30, 2024 | -194.96 Mn |
| Jun 30, 2024 | -306.28 Mn |
| Mar 31, 2024 | -303.52 Mn |
| Dec 31, 2023 | -294.06 Mn |
| Sep 30, 2023 | -338.10 Mn |
| Jun 30, 2023 | -81.90 Mn |
| Mar 31, 2023 | 642.25 Mn |
| Dec 31, 2022 | 711.92 Mn |
| Sep 30, 2022 | 437.94 Mn |
| Jun 30, 2022 | 369.68 Mn |
| Mar 31, 2022 | 317.92 Mn |
| Dec 31, 2021 | 403.98 Mn |
| Sep 30, 2021 | 900.65 Mn |